Boettner Institute of Financial Gerontology, Bryn Mawr, Pennsylvania. Papers from various Boettner Institute symposia, exploring the influence of economic issues on aging. Sociological orientation. Aged - congresses. Economics - congresses.
Dr. Cutler, CEO of WCT, has a proven track record. He was Founder and Chairman of Worldwide Clinical Trials, Inc. (“Old WCT”), a global CRO providing a full range of product development services on a global basis to the pharmaceutical and biotechnology industries from 1986-1999, which was successfully merged into another CRO. In addition, he was founder and served as Director of California Clinical Trials, one of the largest Phase I-III clinical pharmacology and investigational sites in the U.S. From 2000 to 2006, he was the founder of and served as President and CEO of Alamo Pharmaceuticals, LLC. Dr. Cutler is a board-certified psychiatrist, and is also board-qualified in both neurology and clinical pharmacology. He was active at the National Institutes of Health for over nine years in a variety of positions such as Deputy Clinical Director of the National Institute on Aging, and Chief, Section on Brain Aging and Dementia. Currently, he is President of the American Foundation for Clinical Pharmacology, and serves on a special emphasis panel review committee for the National Institute on Aging for the National Institutes of Health. Dr. Cutler has been invited to give several hundred international and national presentations in the areas of aging, clinical pharmacology, and drug development, and has authored over 226 publications including nine books on the topics of clinical pharmacology, aging, Alzheimer’s disease, schizophrenia, anxiety disorders, and diabetes.